GRCE Earnings Grace Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| FY 2026 | 2026-03-31 | -0.47 | 2026-06-18 | 10-K |
| Q3 2026 | 2025-12-31 | -0.41 | 2026-02-12 | 10-Q |
| Q2 2026 | 2025-09-30 | -0.27 | 2025-11-13 | 10-Q |
| Q1 2026 | 2025-06-30 | -0.21 | 2025-08-12 | 10-Q |
| FY 2026 | 2025-03-31 | -0.79 | 2026-06-18 | 10-K |
| Q3 2026 | 2024-12-31 | -0.89 | 2026-02-12 | 10-Q |
| Q2 2026 | 2024-09-30 | -0.53 | 2025-11-13 | 10-Q |
| Q1 2026 | 2024-06-30 | -0.24 | 2025-08-12 | 10-Q |
| FY 2025 | 2024-03-31 | -1.35 | 2025-06-23 | 10-K |
| Q3 2025 | 2023-12-31 | -1.09 | 2025-02-13 | 10-Q |
| Q2 2025 | 2023-09-30 | -0.97 | 2024-11-13 | 10-Q |
| Q1 2024 | 2023-06-30 | -0.54 | 2024-08-09 | 10-Q |
| FY 2024 | 2023-03-31 | -5.71 | 2024-06-21 | 10-K |
| Q3 2024 | 2022-12-31 | -1.80 | 2024-02-12 | 10-Q |
| Q2 2024 | 2022-09-30 | -1.28 | 2023-11-13 | 10-Q |
| Q1 2023 | 2022-06-30 | -0.61 | 2023-08-11 | 10-Q |
| FY 2023 | 2022-03-31 | -0.27 | 2023-06-23 | 10-K |
| Q3 2022 | 2021-12-31 | -0.23 | 2023-02-14 | 10-Q |
| Q2 2022 | 2021-09-30 | -0.07 | 2022-11-14 | 10-Q |
| Q1 2022 | 2021-06-30 | -0.12 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.